Concord Medical Services (NYSE:CCM) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?

Shares of Concord Medical Services Holdings Limited (NYSE:CCM) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.25 and traded as high as $5.11. Concord Medical Services shares last traded at $5.0790, with a volume of 32,136 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Concord Medical Services in a report on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Concord Medical Services Stock Performance

The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33. The firm’s 50-day moving average price is $4.83 and its two-hundred day moving average price is $4.25.

Concord Medical Services (NYSE:CCM) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) earnings per share (EPS) for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.